Introduction
There has been substantial investment in sequencing and initial annotation of the first filamentous fungal genomes. This collection will expand substantially in the next few years. Genomics gives new tools for fungal biology that should allow more rapid transfer of ideas, knowledge and expertise between specialist areas. Now is therefore a good time to consider how to make best use of these data as postgenomics becomes less glamorous and more open-ended.
The aspergilli provide a good example of what can be gained from genome sequences and highlights some of the problems. The interest in this group comes from their importance as pathogens and allergens of humans [Aspergillus fumigatus; Neosartorya fischeri (teleomorph of A. fischerianus), its little-studied, non-pathogenic close relative; A. flavus; and the very rarely pathogenic A. clavatus and A. terreus], plant pathogens (A. flavus; A. parasiticus), industrial organisms (A. oryzae; A. niger; A. terreus) and as a model organism (A. nidulans). So far, the genome sequence of nine species has been partially or fully completed. The sequences of three (A. nidulans, A. fumigatus, A. oryzae) were published at the end of 2005, with the sequence of one more (A. niger) completed but not publicly available (Galagan et al., 2005a; Nierman et al., 2005; Machida et al., 2005) . Assembled genome sequences for A. clavatus, A. flavus, A. terreus, N. fischeri and further strains of A. fumigatus and A. niger are also at or near completion and there are also some data for A. parasiticus (see Table 1 ; 'Aspergillus Genomics' on the Aspergillus website http:// www.aspergillus.org.uk/indexhome.htm; Baker, 2006; Payne et al., 2006; Wortman et al., 2006) . The initial genomic and first post-genomic analyses bring out the following issues.
Fungal genome data and the research community
Convenient worldwide access to the genome data is an obvious requirement, with a need for continued maintenance and additions. As an example, the current A. nidulans genome website focuses on the outcome of the sequencing project, providing access to gene predictions and initial annotation, views of genome features, downloads of DNA sequences and predicted protein sequences and a BLAST search facility (http://www.broad.mit.edu/annotation/fungi/aspergillus/index.html). Other web resources for A. nidulans, such as the gene lists and linkage maps curated at the University of Glasgow, UK (http://www.gla. ac.uk/Acad/IBLS/molgen/aspergillus/), and the genetic resources maintained at the Fungal Genetics Stock Center, Missouri, USA (http://www.fgsc.net/asperg.html), remain to be integrated. The benefits of continued updating can be seen from the Saccharomyces cerevisiae genome site (http:// www.yeastgenome.org), where sequencing was ostensibly completed a decade ago. Nevertheless, the database is still being corrected for sequence, splicing and other fundamental features as well as providing increasingly detailed functional annotation. The integration of additional datasets, including microarray, proteomic and metabolomic studies, adds value to the genome sequence. One additional aspect that needs consideration is the way in which the data Wortman et al. (2006) are organized. Convergence towards one web-interface style for displaying and manipulating genomic data would lower the learning threshold for researchers beginning to take a genomic view of their favourite filamentous fungus.
It is unrealistic to expect that the same level of resource will be available for every fungus. Of the 1.6 million fungal species that may exist, only about 80 000 have been described at some scientific level (Hawksworth, 1991) . The number studied in detail is even smaller, with researchers frequently focusing on only one particular feature of a species. The list of filamentous fungi sequenced to date comprises many of the well-known major model, pathogenic and economically important species. In addition to aspergilli they include However, most of the fungal genomes that are now being sequenced, and which will be sequenced in future, rely on very small resources of human expertise and existing information.
The difficulties experienced in funding living microbial culture collections and curating museum specimens, despite their value for scientific research, industry and human culture, indicates a path to avoid. A solution may come from the electronic nature of genomic data so that strategies for many members of the research community to maintain and develop genome resources over decades are feasible. The start of the genomic era for filamentous fungi is the time to implement such strategies. The Eurofungbase project (http://www.eurofung.net/), supported by the European Union, is an example of one initiative within the Aspergillus research community. It aims to use the Aspergillus genome sequences to draw together the fragmented knowledge on aspergilli to benefit researchers working with each species within the fields of biotechnology and health. Events such as annotation jamborees are planned to harness expertise within the community.
Genome annotation
An accurate catalogue of the genes within the genome is an obvious goal that would greatly facilitate post-genomic research, and the Aspergillus genomes fall short of this at the (Galagan et al., 2005b) .
Predicting function from sequence continues to be a challenge, especially within secondary metabolism, which is the reason for sustained academic, commercial and medical interest in several aspergilli. The focused research within secondary metabolites, such as statin biosynthesis in A. terreus, provides expertise and resources with a reason to address specific pathways and classes of genes. The role of toxins in A. fumigatus pathogenicity is another longstanding research question and the genome sequence has already aided location of biosynthetic genes for some of these toxins (Maiya et al., 2006) .
Comparative genome analysis
Comparative analysis will be an essential part of the interpretation of future fungal genomes, especially since the specific interests of many small research communities mean that organism-specific data are limited. Initial comparisons between the first three Aspergillus sequences have shown the value of this approach, as well as indicating the need for improved tools (Galagan et al., 2005a) . Several further Aspergillus species were selected for sequencing to enable detailed comparisons between genomes of much more closely related species that differed in pathogenicity or other properties (Fungal Genome Initiative Steering Committee, 2003). The preliminary comparison of A. fumigatus with A. clavatus and N. fischeri suggests that these hopes have been fulfilled . The genomes of A. oryzae and A. flavus also appear very similar, with both enriched for secondary metabolism, although the metabolome of A. flavus appears more complex (Payne et al., 2006) . Comparative analysis of A. nidulans, A. fumigatus and A. oryzae led to the realization that it may be possible to develop the power of genetic analysis in the latter species because the genes involved in the mating process in A. nidulans are also found in the others (Galagan et al., 2005a; Nierman et al., 2005) .
Although secondary metabolites are the reason for interest in many fungi, if these gene clusters lie within heavily rearranged subtelomeric regions, as in the first sequenced aspergilli, comparative methods may not be helpful (Galagan et al., 2005a) . Interestingly, the variation between two sequenced strains of A. fumigatus was located primarily in subtelomeric regions, indicating that this area may be important in maintaining species variability . Nevertheless, identification of the putative cluster of genes necessary for the biosynthesis of gliotoxin in A. fumigatus was possible through a comparative genomics approach (Gardiner & Howlett, 2005) .
The development of infrastructure for comparative functional genomics in fungal species, such as through the eFungi project (http://www.e-fungi.org.uk/) funded by a UK Research Council, is therefore a welcome step. This project aims to facilitate systematic comparisons of fungal genomes through developing a data warehouse to integrate data from several species, initially 23 fungi (including several yeast and dimorphic species) and two oomycetes. A library of bioinformatics queries is being developed to analyse the data, so that less-well-studied species can be readily compared with better-understood species. The first studies from the project will test the effectiveness of this comparative genomic infrastructure and are planned to focus on the scientific question of the nature and origin of fungal pathogenicity.
Comparative analysis will also lead to deeper understanding of the control of gene expression, building on knowledge from a few well-studied systems (e.g. Caddick, 2004) . The significance of conserved non-coding regions, as well as sets of co-regulated genes with no apparent conserved upstream or downstream motifs, is where combined genome analyses and experimental studies will yield insights that are not apparent from studies of individual genes or species (e.g. Galagan et al., 2005a) .
Tools for functional analysis
The small size and specialized nature of the research communities working with most filamentous fungi provides only a fragmentary picture of their biology. The model fungi, such as A. nidulans, give a more rounded view as well as insights into fundamental areas of all eukaryotic biology. Research with A. nidulans started in the 1950s (Pontecorvo et al., 1953) and continues to advance understanding of metabolic regulation, pH control, DNA repair, controlled RNA degradation, morphogenesis, chromatin structure, cell cycle control, cytoskeletal function, mitochondrial DNA structure and other aspects of eukaryotic genetics and cell physiology. The existence of a well-characterized sexual cycle (teleomorph Emericella nidulans) and molecular biology tools make it a valuable laboratory species. A well-annotated and supported genome sequence will take A. nidulans into the post-genomic era, repaying the effort that will be needed to achieve this.
The availability of tools for more rapid functional analysis is important but many rely on a well-annotated genome.
There have been technical developments in tagging and deletion by homologous integration in Aspergillus species so that the development of large-scale collections of mutants is becoming feasible (e.g Yang et al., 2004; Ferreira et al., 2006; Krappmann, 2006; Nayak et al., 2006) . Several types of microarrays have been developed and used for the first global views of gene expression in aspergilli. A. nidulans microarrays have added to the already complex picture of carbon catabolite repression as mediated by creA (Mogensen et al., 2006) while, in combination with manipulation of expression of laeA, a global regulator of secondary metabolism, microarrays have started to reveal the secondary metabolome (Bok et al., 2006) . The technology for proteomics is still developing, but the first applications to A. fumigatus have shown that different carbon sources cause changes to the proteome (Kniemeyer et al., 2006) .
Before the number of these studies increases, the question of how to get more value from the raw data through making it accessible for reanalysis by future researchers needs to be answered. Data standards are emerging but a location and responsibility for maintenance of these post-genomic resources needs thought.
Applied versus pure science
The life sciences and biotechnology are widely recognized as the next stage in the knowledge-based economy, creating new work, social and entrepreneurial opportunities. The status of aspergilli as pathogens and industrial organisms means that their genomes are important for commercial as well as academic purposes and several firms have started sequencing projects (see Table 1 ). Indeed, the first completed sequencing and annotation project for A. niger was funded privately by the major Dutch food and pharmaceutical ingredients company DSM and provides an example of the real commercial potential of fungal genome sequences. Commercial exploitation of the A. oryzae genome is also well under way (Abe et al., 2006) .
A. niger is important as the major world source of citric acid and higher-value enzyme products including pectinases, proteases, amyloglucosidases, cellulases, hemicellulases and lipases. Enzymes from A. niger, including ones from recombinant strains where the fungus is used for expression, have been repeatedly assessed as 'generally regarded as safe' by the World Health Organization and US Food and Drug Administration (Schuster et al., 2002) . DSM's 2005 annual company report (Royal DSM N.V., 2005) indicated that genomic information has been used to optimize production of 7-aminodeacetoxycephalosporanic acid, a commercial intermediate for semisynthetic penicillins and cephalosporins. Over 200 new proteases were identified during annotation and at least two have now reached commercial products. These are 'Brewer's Clarex', a proline-specific endoprotease processing aid to prevent chill-haze in beer (Lopez & Edens, 2005) , and a protease to produce milk peptides for new 'Peptopro' and 'Multipower' sports drinks (Edens et al., 2005) . One consequence of limited access to A. niger genome information has been the initiation of several public sequencing projects for this species (see Table 1 and Baker, 2006) . The resulting complete and partial sequences unintentionally provide data on intraspecific variation.
Exploitation of the genomes of A. fumigatus, N. fischeri and others could lead to new medical products as well as advancing understanding of the nature of Aspergillus pathogenicity (Krappmann, 2006; Wortman et al., 2006) . The world market for antifungal drugs is estimated to reach £4.6 billion in 2007, even though many have serious side-effects and are ineffective against species such as A. fumigatus, and antifungal resistance is increasing. There is also a lack of effective rapid diagnostic tests. Post-genomics offers new approaches to these problems.
Reconciling differing academic and commercial objectives will continue to be one aspect of the exploitation of fungal genomes. This is immediately obvious in species that are already of commercial value, but advances in comparative genomics and functional prediction may give new monetary value to currently worthless facts.
The future challenge
We are at the start of post-genomic biology in the filamentous fungi. The first genome sequences of the aspergilli have provided insights into their biology and leads for new commercial products. However, they have also highlighted the problems that arise after the sequencing is over, especially if fungal genomes are to become everyday tools for all biologists rather than the province of specialist genome scientists. After succeeding with the sequencing challenge, the scientific community has to resolve how to retain value into the future.
